Venkatesan Jayaprakash Selected Research

N-hydroxy-N'-aminoguanidine

1/2011

A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Venkatesan Jayaprakash Research Topics

Disease

10	Neoplasms (Cancer) 11/2021 - 03/2010
4	Dengue (Dengue Fever) 11/2021 - 11/2014
3	Leukemia 10/2017 - 01/2011
2	COVID-19 06/2022 - 01/2021
2	Hyperglycemia 01/2021 - 10/2017
2	Carcinogenesis 01/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 10/2017 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2016 - 12/2008
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Insulin Resistance 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 04/2019
1	Ovarian Neoplasms (Ovarian Cancer) 02/2019
1	Iron Overload 01/2019
1	Infections 11/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2017
1	Prostatic Neoplasms (Prostate Cancer) 09/2016
1	Ebola Hemorrhagic Fever 01/2015
1	Neglected Diseases 11/2014

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 11/2021 - 07/2016
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2014
3	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 10/2015
3	EnzymesIBA 01/2020 - 10/2015
2	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 10/2017
2	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2021 - 10/2017
2	AntioxidantsIBA 01/2021 - 01/2020
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 10/2017
2	Hormones (Hormone)IBA 02/2019 - 09/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2017 - 01/2011
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2017 - 01/2011
2	Monoamine Oxidase (MAO)IBA 08/2016 - 12/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 03/2010
2	LigandsIBA 01/2015 - 01/2013
1	SARS-CoV-2 3C-like proteinaseIBA 06/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2021
1	PlastoquinoneIBA 11/2021
1	Dengue VaccinesIBA 11/2021
1	phenylpiperazineIBA 11/2021
1	acetamideIBA 01/2021
1	HydrogenIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	ferulic acid (sodium ferulate)IBA 01/2021
1	mycobactinsIBA 01/2021
1	2-Acetylaminofluorene (2 Acetylaminofluorene)IBA 01/2020
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	QuinazolinonesIBA 01/2020
1	Benzo(a)pyreneIBA 04/2019
1	Cisplatin (Platino)FDA LinkGeneric 04/2019
1	Cyclin-Dependent Kinase 4IBA 03/2019
1	TubulinIBA 03/2019
1	Phytoestrogens (Phytoestrogen)IBA 02/2019
1	Atrial Natriuretic Factor (ANF)IBA 02/2019
1	Chelating AgentsIBA 01/2019
1	IronIBA 01/2019
1	TransferasesIBA 01/2018
1	VaccinesIBA 11/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2017
1	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2017
1	HydrazonesIBA 10/2017
1	ThiosemicarbazonesIBA 10/2017
1	ThiazolidinedionesIBA 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	Phosphates (Orthophosphate)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 10/2015
1	romidepsin (FK228)FDA Link 01/2015
1	belinostatIBA 01/2015
1	N-hydroxy-N'-aminoguanidineIBA 01/2011

Therapy/Procedure

3	Therapeutics 11/2021 - 01/2016
1	Drug Therapy (Chemotherapy) 01/2011